標的療法の世界市場は、2021年の1,009億ドルから、2026年までに1,426ドルに拡大し、2021年から2026年の予測期間におけるCAGRは7.2%と予想されます。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Market Size and Evolution
Chapter- 3: Market Overview
Cancer Burden
Causes of Cancer
Cancer-Causing Genes
Immune System and Cancer
Cancer Prevention
Types of Cancer Treatment
Market Dynamics
Chapter- 4: Impact of COVID-19 on Market
Overview
Impact of COVID-19 on Cancer Care
Chapter- 5: Regulatory Aspects
Overview
United States
Europe
Japan
India
China
Chapter- 6: Market Breakdown by Type of Targeted Therapy
Overview
Small Molecules
Monoclonal Antibodies
Chapter- 7: Market Breakdown by Application
Overview
Lung Cancer
Breast Cancer
Blood Cancer
Colorectal Cancer
Other Cancers
Chapter- 8: Market Breakdown by Region
Introduction
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 9: Industry Structure
Company Landscape
Pipeline Analysis
Chapter- 10: Company Profiles
AMGEN INC.
ASTRAZENECA
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB
F. HOFFMANN-LA ROCHE LTD.
MERCK & CO., INC.
NOVARTIS AG
PFIZER
TAKEDA PHARMACEUTICAL CO., LTD.
Chapter- 11: Appendix: Acronyms
Table 52 : Acronyms Used in This Report
